Axogen (AXGN) Income from Continuing Operations (2010 - 2026)
Axogen (AXGN) posted quarterly Income from Continuing Operations of 1820000.0 for Q2 2026, down 2175.0% year-over-year from 87710.84 in Q2 2025, and up 34.01% quarter-over-quarter from 2758000.0 in Q1 2026.
Axogen (AXGN) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Axogen's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 1820000.0 for Q2 2026.
- In Q2 2026, Income from Continuing Operations fell 2175.0% year-over-year to 1820000.0; the TTM figure through Jun 2026 stood at 14432000.0 (down 150.56% YoY), while the FY2025 annual figure was 67579000.0, down 6.25% from the prior year.
- Income from Continuing Operations for Q2 2026 stood at 1820000.0, up from 2758000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 393000.0 in Q3 2025, with the low at 12553000.0 in Q1 2022.
- The 5-year median for Income from Continuing Operations is 4624000.0 (2022), against an average of 4882000.0.
- Peak annual rise in Income from Continuing Operations reached 120.54% in 2025, while the deepest fall reached 7905.47% in 2025.
- Axogen's Income from Continuing Operations stood at 4547000.0 in 2022, then declined by 3.39% to 4701000.0 in 2023, then surged by 97.28% to 128000.0 in 2024, then sank by 7905.47% to 10247000.0 in 2025, then soared by 82.24% to 1820000.0 in 2026.
- Business Quant data shows AXGN's Income from Continuing Operations at 1820000.0 in Q2 2026, 2758000.0 in Q1 2026, and 10247000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Axogen | 2.69 Bn | 2.58 Bn | 50.67 Mn | -1.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.82 Mn |
| Mar 31, 2026 | -2.76 Mn |
| Dec 31, 2025 | -10.25 Mn |
| Sep 30, 2025 | 393,000.00 |
| Jun 30, 2025 | -80,000.00 |
| Mar 31, 2025 | -3.64 Mn |
| Dec 31, 2024 | -128,000.00 |
| Sep 30, 2024 | -1.91 Mn |
| Jun 30, 2024 | -2.39 Mn |
| Mar 31, 2024 | -6.59 Mn |
| Dec 31, 2023 | -4.70 Mn |
| Sep 30, 2023 | -5.30 Mn |
| Jun 30, 2023 | -8.27 Mn |
| Mar 31, 2023 | -8.32 Mn |
| Dec 31, 2022 | -4.55 Mn |
| Sep 30, 2022 | -5.92 Mn |
| Jun 30, 2022 | -9.09 Mn |
| Mar 31, 2022 | -12.55 Mn |
| Dec 31, 2021 | -5.27 Mn |
| Sep 30, 2021 | -7.89 Mn |